Physician profile
Basharat Ali
NPI 1508930983
$392.64
in general payments reported to CMS, 2019-2025
7 companies · $38.61 in 2025
The $38.61 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.01 · 2020: $11.30 · 2021: $48.62 · 2022: $20.92 · 2023: $3.08 · 2024: $186 · 2025: $38.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $227.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $203.18 | 2023-2025 | Filspari |
| Otsuka America Pharmaceutical, INC. | $61.20 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.11 | 2019-2020 | |
| Glaxosmithkline, LLC. | $28.93 | 2021 | |
| Akebia Therapeutics INC | $24.61 | 2024 | Vafseo |
| Janssen Pharmaceuticals, INC | $20.92 | 2022 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basharat Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.